The Role of Microglia in Aging and Neurodegenerative Disease
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 25 August 2024 | Viewed by 165
Special Issue Editor
Interests: the mechanisms of TGF-beta-mediated modulation of microglia functions under physiological and pathological conditions; microglia development/maturation, microglia functions during postnatal CNS development, and microglia in the aged and diseased CNS are addressed using transgenic mouse models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Microglia significantly change their morphological and functional features during aging as well as during the course of neurodegenerative diseases, thereby contributing to the onset and progression of several CNS pathologies. However, whether microglia reactivity has beneficial or detrimental effects and consequences seems to depend on the particular disease. Moreover, the crosstalk with peripheral immune cells and the gut–brain axis involved in the regulation of age-dependent and disease-specific microglia reactions are only partially understood. We aim to elucidate different microglia reaction states found in distinct CNS pathologies and their contribution to disease outcomes.
Major questions include how microglia functions are regulated during aging and neurodegenerative processes and which endogenous and exogenous factors might bear therapeutic potential for the treatment of neurodegenerative diseases. Furthermore, the understanding of how the gut–brain axis and metabolic changes regulate the reactivity of microglia in CNS diseases will be a major purpose of this Special Issue.
Submissions of original research and review manuscripts focusing on microglia activation and the role of microglia in neurodegenerative diseases of the brain and spinal cord are welcome. We hope to comprehensively summarize and elucidate the different microglia activation states related to neurodegeneration and hope to increase the overall understanding of microglia in neurodegenerative diseases.
Prof. Dr. Björn Spittau
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microglia
- neurodegenerative diseases
- disease-associated microglia (DAM)
- microglia activation
- Alzheimer's disease
- Parkinson’s disease
- ischemic stroke
